REPRODUCTIVE HORMONE MARKET ANALYSIS

Reproductive Hormone Market, by Hormone Type (Testosterone, Estrogen, and Progesterone), by Application (Menopausal and Menstrual Disorders, Premenstrual Syndrome (PMS), Hypogonadism, and Others), by End User (Hospitals, Specialty Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI3185
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Reproductive Hormone Market - Restraints

Increasing drugs recalls is a major factor responsible for restraining growth of the reproductive hormone market. For instance, in 2017, Medisca Inc. voluntarily issued recalls for its range of hormone drugs including ESTRADIOL, USP Bulk (Hemihydrate), ESTRADIOL, ESTRONE, USP Bulk, and ESTRIOL, USP (Micronized) Bulk, due to lack of standard good manufacturing practices which was noted by U.S. FDA inspection.